Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Guardian Pharmacy Services, Inc. GRDN

Set alert

Price alert · GRDN

All alert types
40.00 USD -0.69 -1.70%

At close · Nov 2

40.00 0.00 0.00%

After hours · Nov 2, 4:01 PM ET

Bid
39.98 × 100
Ask
40.21 × 500
39.71 Day range 40.57
26.34 52-week range 48.33
YTD
+32.93%
1 year
+42.65%
Open
40.50
Prev close
40.69
Mkt cap
2.53B
Vol
410.30K
Avg vol
494.45K
EPS
1.03
P/E
38.84
Div yield
0.00%
More statistics
Low
39.71
High
40.57
Forward P/E
27.89
Beta
0.06
Short ratio
3.76
Inst. own
60.69%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
41.05
200-d avg
38.08
1y target
49.86

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 6, 2026Earnings: 0.29; estimate 0.2617; surprise 10.81%
  • Aug 7, 2026Rating: Oppenheimer · Outperform → Outperform
  • Sep 21, 2026Rating: Truist Securities · Buy → Buy
  • Sep 23, 2026Rating: Keybanc · — → Overweight
Signals (27)
NameDateAgo
MACD: Buy SignalOct 29, 20264 days ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BullishOct 2, 20261 month ago
SMA: BullishOct 1, 20261 month ago
SMA: BearishSep 28, 20261 month ago
SMA: BearishSep 28, 20261 month ago
MACD: Sell SignalSep 24, 20261 month ago
RSI: OverboughtSep 14, 20261 month ago
RSI: OverboughtSep 10, 20261 month ago
SMA: BullishSep 3, 20262 months ago
SMA: BullishSep 3, 20262 months ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
SMA: BearishAug 4, 20263 months ago
SMA: BearishAug 4, 20263 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BullishAug 3, 20263 months ago

Financial health

Altman Z-Score

12.92 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E 38.1×
FY 2018: 66.7×FY 2019: 44.4×FY 2020: 48.5×FY 2021: 59.3×FY 2022: 27.6×FY 2023: 41.0×FY 2024: -11.4×FY 2025: 38.1×
FY 2018 5y median 38.1× FY 2025
P/S 1.3×
FY 2018: 1.6×FY 2019: 1.4×FY 2020: 1.3×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 1.0×FY 2025: 1.3×
FY 2018 5y median 1.1× FY 2025
P/B 9.1×
FY 2018: 28.6×FY 2019: 0.0×FY 2020: 25.3×FY 2021: 40.7×FY 2022: 22.8×FY 2023: 34.5×FY 2024: 8.8×FY 2025: 9.1×
FY 2018 5y median 22.8× FY 2025
P/FCF 23.3×
FY 2018: 28.9×FY 2019: 23.4×FY 2020: 22.0×FY 2021: 19.8×FY 2022: 30.7×FY 2023: 17.3×FY 2024: 30.2×FY 2025: 23.3×
FY 2018 5y median 23.3× FY 2025
EV/EBITDA 19.2×
FY 2018: 26.5×FY 2019: 20.8×FY 2020: 20.9×FY 2021: 21.8×FY 2022: 15.2×FY 2023: 17.7×FY 2024: -29.5×FY 2025: 19.2×
FY 2018 5y median 17.7× FY 2025
EV/Sales 1.3×
FY 2018: 1.7×FY 2019: 1.5×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.3×
FY 2018 5y median 1.1× FY 2025
FCF Yield 4.3%
FY 2018: 3.5%FY 2019: 4.3%FY 2020: 4.5%FY 2021: 5.1%FY 2022: 3.3%FY 2023: 5.8%FY 2024: 3.3%FY 2025: 4.3%
FY 2018 5y median 4.3% FY 2025

Profitability

Gross Margin 19.5%
FY 2018: 20.5%FY 2019: 20.5%FY 2020: 20.0%FY 2021: 20.4%FY 2022: 20.4%FY 2023: 19.9%FY 2024: 19.9%FY 2025: 19.5%
FY 2018 5y median 19.9% FY 2025
Operating Margin 6.1%
FY 2018: 4.3%FY 2019: 4.9%FY 2020: 4.4%FY 2021: 3.8%FY 2022: 5.7%FY 2023: 3.9%FY 2024: -5.1%FY 2025: 6.1%
FY 2018 5y median 3.9% FY 2025
Net Margin 3.4%
FY 2018: 2.4%FY 2019: 3.1%FY 2020: 2.7%FY 2021: 2.1%FY 2022: 3.9%FY 2023: 2.3%FY 2024: -7.1%FY 2025: 3.4%
FY 2018 5y median 2.3% FY 2025
ROE 23.9%
FY 2018: 43.1%FY 2019: 0.0%FY 2020: 51.8%FY 2021: 68.2%FY 2022: 82.9%FY 2023: 84.7%FY 2024: -61.2%FY 2025: 23.9%
FY 2018 5y median 68.2% FY 2025
ROIC 22.9%
FY 2018: 21.3%FY 2019: 27.0%FY 2020: 22.3%FY 2021: 22.1%FY 2022: 32.4%FY 2023: 26.2%FY 2024: -34.3%FY 2025: 22.9%
FY 2018 5y median 22.9% FY 2025
ROA 11.9%
FY 2018: 8.1%FY 2019: 11.1%FY 2020: 9.2%FY 2021: 6.9%FY 2022: 13.8%FY 2023: 8.8%FY 2024: -27.2%FY 2025: 11.9%
FY 2018 5y median 8.8% FY 2025

Growth (YoY)

Revenue 17.9%
FY 2018: 0.0%FY 2019: 16.3%FY 2020: 5.4%FY 2021: 7.6%FY 2022: 14.8%FY 2023: 15.1%FY 2024: 17.4%FY 2025: 17.9%
FY 2018 FY 2025
Operating Income 241.3%
FY 2018: 0.0%FY 2019: 31.5%FY 2020: -6.0%FY 2021: -6.0%FY 2022: 72.4%FY 2023: -21.2%FY 2024: -253.7%FY 2025: 241.3%
FY 2018 FY 2025
EPS (diluted) 144.1%
FY 2018: 0.0%FY 2019: 50.0%FY 2020: -8.3%FY 2021: -18.2%FY 2022: 114.8%FY 2023: -32.8%FY 2024: -553.8%FY 2025: 144.1%
FY 2018 FY 2025
Free Cash Flow 94.1%
FY 2018: 0.0%FY 2019: 23.6%FY 2020: 6.4%FY 2021: 11.2%FY 2022: -35.5%FY 2023: 77.2%FY 2024: -26.1%FY 2025: 94.1%
FY 2018 FY 2025

Financial Health

Current Ratio 1.4×
FY 2018: 1.2×FY 2019: 1.0×FY 2020: 1.1×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 1.1×FY 2025: 1.4×
FY 2018 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 1.1×
FY 2018 5y median 0.7× FY 2025
Debt / Equity 0.2×
FY 2018: 1.3×FY 2019: 0.0×FY 2020: 1.5×FY 2021: 2.3×FY 2022: 1.5×FY 2023: 2.5×FY 2024: 0.2×FY 2025: 0.2×
FY 2018 5y median 1.5× FY 2025
Net Debt / EBITDA -0.3×
FY 2018: 1.1×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 0.9×FY 2022: 0.9×FY 2023: 1.2×FY 2024: -0.6×FY 2025: -0.3×
FY 2018 5y median 0.9× FY 2025
Interest Coverage 134×
FY 2018: 13.6×FY 2019: 15.1×FY 2020: 14.9×FY 2021: 18.4×FY 2022: 27.0×FY 2023: 14.3×FY 2024: -19.2×FY 2025: 134×
FY 2018 5y median 18.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 2.9%FY 2019: 3.5%FY 2020: 1.1%FY 2021: 1.8%FY 2022: 3.2%FY 2023: 3.9%FY 2024: 2.8%FY 2025: 0.0%
FY 2018 5y median 2.8% FY 2025
Payout Ratio 0.0%
FY 2018: 190.7%FY 2019: 157.8%FY 2020: 54.2%FY 2021: 106.4%FY 2022: 87.0%FY 2023: 160.7%FY 2024: -41.0%FY 2025: 0.0%
FY 2018 5y median 87.0% FY 2025

Annual · latest fiscal year ends 2025-12-31